Literature DB >> 11193722

Evaluation of the Maruyama computer program accuracy for preoperative estimation of lymph node metastases from gastric cancer.

S Guadagni1, G de Manzoni, M Catarci, M Valenti, G Amicucci, G De Bernardinis, C Cordiano, M Carboni, K Maruyama.   

Abstract

Controversy still exists about the optimal lymph node (LN) dissection for potentially curable gastric cancer. For rational LN dissection it is important to know the incidence of metastasis at each LN station. For this purpose a computer program was developed using data from 4302 primary gastric cancers treated at the National Cancer Center Hospital in Tokyo between 1969 and 1989. To evaluate the accuracy of the computer program, the differences between the individual reports generated by the computer and the stored data were investigated in 282 Italian patients submitted to curative gastrectomy and D2 or more extended LN dissections for gastric cancer. Receiver operating characteristic (ROC) analysis was used to assess the sensitivity and specificity of the program for predicting LN metastases in each of the 16 regional LN stations. The computer program showed good predictive ability for LN metastases in most of the 16 LN stations, as the areas under the curve ranged from 0.741 (station 15) to 0.944 (station 8), with a mean of 0.856. A critical cutoff point of 18% of the program's expected percentage was the value maximizing the validity of the prediction. Using an "absolute" cutoff point of 0%, the overall rate of false-negative (FN) predictions in 176 N+ patients was 11.9%; of these, 11 (6.2%) were absolute FNs, in which the program totally failed to estimate LN metastases; the remaining 10 cases (5.7%) were relative FNs because the specific prediction was positive for a different depth of stomach invasion. The low number of D3/D4 lymph-adenectomies in the historical database may affect the low estimate of metastases to N3/N4 nodes generated by the program. Based on these data, the program predicts with good accuracy the extent of LN metastases from gastric cancer, but it is not recommended for directing the surgeon to perform more extensive lymphadenectomy.

Entities:  

Mesh:

Year:  2000        PMID: 11193722     DOI: 10.1007/s002680010276

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  18 in total

1.  Prospective, comparative study for the evaluation of lymph node involvement in gastric cancer: Maruyama computer program versus sentinel lymph node biopsy.

Authors:  Dezső Tóth; Miklós Török; Zsolt Kincses; László Damjanovich
Journal:  Gastric Cancer       Date:  2012-06-29       Impact factor: 7.370

2.  Improved regional control and survival with "low Maruyama Index" surgery in gastric cancer: autopsy findings from the Dutch D1-D2 Trial.

Authors:  Scott A Hundahl; Koen C M J Peeters; E Klein Kranenbarg; Henk Hartgrink; Cornelis J H van de Velde
Journal:  Gastric Cancer       Date:  2007-06-25       Impact factor: 7.370

Review 3.  An evidence-based review of the surgical treatment of gastric adenocarcinoma.

Authors:  Ugwuji N Maduekwe; Sam S Yoon
Journal:  J Gastrointest Surg       Date:  2011-03-12       Impact factor: 3.452

Review 4.  Treatment of early gastric cancer in the Western World.

Authors:  Elfriede Bollschweiler; Felix Berlth; Christoph Baltin; Stefan Mönig; Arnulf H Hölscher
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

Review 5.  Clinical significance of lymphadenectomy in patients with gastric cancer.

Authors:  Dezső Tóth; János Plósz; Miklós Török
Journal:  World J Gastrointest Oncol       Date:  2016-02-15

6.  Long-term results of tailored D(2) lymph node dissection after R(0) surgery for gastric cancer.

Authors:  Marco Catarci; Leonardo Antonio Montemurro; Sabrina Ghinassi; Antonio Di Cintio; Leonardo Leone; Luigi Marino Cosentino; Maria Antonietta Viarengo; Giovanni Battista Grassi
Journal:  Updates Surg       Date:  2011-03-29

Review 7.  Historical assumptions of lymphadenectomy.

Authors:  Paolo Morgagni; Domenico Tringali; Giuliano La Barba; Giovanni Vittimberga; Giorgio Ercolani
Journal:  Transl Gastroenterol Hepatol       Date:  2016-12-08

8.  Low Maruyama index surgery for gastric cancer: blinded reanalysis of the Dutch D1-D2 trial.

Authors:  K C M J Peeters; S A Hundahl; E Klein Kranenbarg; H Hartgrink; C J H van de Velde
Journal:  World J Surg       Date:  2005-12       Impact factor: 3.352

9.  Evaluation of the adequacy of lymph node dissection in pylorus-preserving gastrectomy for early gastric cancer using the maruyama index.

Authors:  Moon-Won Yoo; Do Joong Park; Hye Seong Ahn; Sang-Ho Jeong; Hyuk-Joon Lee; Woo Ho Kim; Hyung-Ho Kim; Kuhn Uk Lee; Han-Kwang Yang
Journal:  World J Surg       Date:  2010-02       Impact factor: 3.352

10.  Pathological factors affecting gastric adenocarcinoma survival in a Caribbean population from 2000-2010.

Authors:  Patrick O Roberts; Joseph Plummer; Pierre-Anthony Leake; Shane Scott; Tamara G de Souza; Ayesha Johnson; Tracey N Gibson; Barrie Hanchard; Marvin Reid
Journal:  World J Gastrointest Surg       Date:  2014-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.